European Consortium of Lipodystrophies (ECLip)
  • Home
  • Goals
  • Lipodystrophies
    • Classification
  • Groups
    • Austria
      • Foisner
      • Scherer
    • Belgium
      • Unité de Recherche en Biologie Cellulaire (Namur)
      • Cell Systems and Imaging (Ghent)
      • Universitair Ziekenhuis Antwerpen (Antwerp)
    • Bulgaria
    • Cyprus
    • Egypt
    • France
      • Genetic and Acquired Lipodystrophies (Paris)
      • Genetics, Pathophysiology and Therapeutic Approach
      • Paediatric Endocrinology Unit (Paris)
      • INSERM UMR_S 1087 (Nantes)
      • Lille Group (Lille)
      • ​Premature Aging Syndromes & Lipodystrophies​
      • Pediatric Endocrinology and Diabetology (Paris)
    • Germany
      • Hoffmann Group (Halle)
      • Clinic for Transplantation Medicine (Münster)
      • Dep. of Pediatrics and Adolescent Medicine (Ulm)
      • IFB Lipodystrophy Centre (Leipzig)
    • Greece
      • ​Paediatric HIV Referral Unit (Athens)
      • Unit of Reproductive Endocrinology (Thessaloniki)
    • Israel
    • Italy
      • Laminopathy Research Laboratory (Bologna)
      • Human Lipodystrophies (Bologna)
      • Obesity Center-Endocrinology Unit (Pisa)
      • Laboratory of Medical Genetics (Roma)
      • Gene Expression - Microarrays Laboratory (Roma)
    • Lithuania
    • Netherlands
      • AMC Lipodystrophy Group (Amsterdam)
      • Maastricht University Hospital
      • Leiden University Medical Center
      • Amsterdam UMC
    • Norway
    • Oman
    • Peru
    • Poland
    • Portugal
      • Porto University
      • Grupo de Estudo das Lipodistrofias do CMIN (Porto)
    • Russia
    • Slovenia
    • Spain
      • UETeM - Molecular Pathology Group (Santiago)
      • Stem Cell Laboratory (Vizcaya)
      • Rheumatology Division Proteomics Group (A Coruña)
      • Department of Medical Sciences (Ciudad Real)
      • Adipobiology Group (Córdoba)
      • Uniovi (Oviedo)
      • Dep. Biochemistry & Molecular Biology (Barcelona)
      • Clinical Genetics and Rare Diseases (Murcia)
      • Fundación Galega de Medicina Xenómica (Santiago)
      • Complement system IdiPAZ (Madrid)
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
      • Nat. Severe Insulin Resistance Service (Cambridge)
      • Centre for Cardiovascular Science (Edinburgh)
      • University of Aberdeen
    • USA
      • NIDDK (Maryland)
      • University of Michigan
  • Information
    • Advocacy groups
    • Clinical centres
    • Executive board
      • Disclosure
    • Registry
  • News
  • Meetings
    • 2015 World Lipodystrophy Day
    • 2016 ECLip Annual Meeting
    • 2017 ECLip Annual Meeting
    • 2018 ECLip Annual Meeting
    • 2019 ECLip Annual Meeting
      • Gallery
    • 2020 ECLip Annual Meeting
    • 2022 ECLip Annual Meeting
    • 2023 ECLip Annual Meeting
  • Publications
    • POW: Paper of the week
    • Collaborative ECLip Publications
  • Contact

LipoDDx is finally available!

August 4, 2019 at 12:33 am
LipoDDx is the first mobile app to help doctors better characterize the different subtypes of lipodystrophy and it is based on a personal algorithm developed by Prof. David Araújo-Vilar, with the support of the University of Santiago de Compostela, the Galician Health Service (SERGAS) and the International Association of Relative and Affected of Lipodystrophies (AELIP).

More info at: https://www.uetem.com/lipoddx/

Download it FREE from Apple Store and Google Play.


Recent Posts

  • 8th July 2020 Webinar: Link for registration
    7 Jul, 2020
  • Prof. David Araújo-Vilar, elected President of the European Consortium of Lipodystrophies (ECLip)
    19 Oct, 2019
  • ECLip 2019: a success!
    8 Oct, 2019
  • 2020 ECLip Annual Meeting
    24 Sep, 2019
  • LipoDDx is finally available!
    4 Aug, 2019
  • Open Call to hire PhD candidate at UETeM (Spain)
    13 May, 2019
  • 2019 ECLip-AELIP Annual Meeting: Preliminary programme available
    24 Mar, 2019
2019 European Consortium of Lipodystrophies (ECLip)